Metformin for lung cancer prevention and improved survival : a novel approach
Cet article passe en revue les études concernant le rôle de la metformine dans la chimioprévention des cancers du poumon et l'amélioration de la survie des patients atteints de la maladie
Diabetes mellitus has been associated with increased risk for the development of many types of cancer. Metformin, an oral medication and first-line treatment for type 2 diabetes mellitus, has been suggested to reduce cancer risk and mortality in various types of cancer. This study focuses on assessing metformin association with lung cancer as reported in the literature. Recent studies and reviews investigating metformin effects on lung cancer incidence and patient survival are critically and systematically discussed.